TCL Archive Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy. June 30, 2000
TCL Archive As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data. October 22, 2004
TCL Archive DCPC Board Ponders Screening Recommendations: Should NCI Have Policies? If So, What Will They Be? September 26, 1986